Timeline, a consumer health biotech company at the forefront of developing innovative solutions for healthy aging and longevity, raised $66 million in an oversubscribed Series D financing round. This marks a significant milestone for the company and includes strategic investments from two global industry leaders—L’Oréal and Nestlé.
WHO: Timeline was founded in 2007 by Chris Rinsch and Patrick Aebischer as a spinoff of the Swiss Federal Institute of Technology (EPFL) to develop innovative solutions for longevity in the food, beauty, and health sectors. Timeline has developed a proprietary molecule backed by 15 years of research. Mitopure is clinically proven to target a key cellular longevity pathway, by recycling and renewing the powerhouses inside cells, the mitochondria. Optimal mitochondrial function is essential for maintaining cellular energy, which supports muscle strength, cognition, immune resilience, skin vitality, and other important benefits, offering a comprehensive approach to promoting healthspan. This breakthrough technology is backed by more than a decade of research by distinguished scientists, multiple gold-standard clinical studies, and an unparalleled intellectual property portfolio.
WHY: The funds raised will be used to build Timeline into a leading longevity consumer health brand by expanding the science, product categories, and markets across food, beauty, and health sectors.
IN THEIR OWN WORDS: “Longevity is about living healthier for longer and L’Oréal has been working for more than a decade to understand and anticipate what this could mean for beauty,” said Barbara Lavernos, Deputy Chief Executive Officer in charge of Research, Innovation and Technology, L’Oréal Groupe. “Longevity adds a new dimension to beauty, focused on predicting, correcting and even reversing the ageing of our skin, scalp and hair. Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.”
"This strategic collaboration reflects the breakthrough multidimensional approach that we've always believed is necessary to make meaningful advancements for longevity and healthspan," said Patrick Aebischer, co-founder and Chairman of Timeline. “I want to thank L’Oréal for its commitment to longevity solutions rooted in the highest level of science.”
"We have been an investor in Timeline since 2019 and continue to be very impressed with the team and stand behind the exponential potential that the Mitopure technology holds for nutrition to help people age better," said Anna Mohl, CEO of Nestlé Health Science. "We’re excited to have L’Oréal join as an investor and strategic partner to bring this technology to new heights and extend its applications."
DETAILS:
